Stenotrophomonas maltophilia (Hugh) Palleroni and Bradbury
商品貨號
B186223
Strain Designations
WW
Isolation
Gunshot wound of patient treated with ceftazidime, ciprofloxacin, and trimethoprim-sulfamethoxazole after 6 days of therapy, Spokane, WA, 1993
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Preceptrol®
no
Type Strain
no
Antibiotic Resistance
Resistant to ciprofloxacin
Sensitive to trimethoprim-sulfamethoxazole
Medium
ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor
MW Garrison
Special Collection
NCRR Contract
Chain of Custody
ATCC <<--MW Garrison<<--Deaconess Medical Center
Year of Origin
1993
References
Garrison MW, et al. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40: 2859-2864, 1996. PubMed: 9124855
